Seigo Yukisawa

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Chigusa Morizane, Takuji Okusaka, Junki Mizusawa et al. · Annals of Oncology · 2019 · 334 citations

Medicine, Oncology, Chemotherapy +7

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo et al. · The Lancet Oncology · 2019 · 284 citations · Full text

Medicine, Oncology, Pharmacology +13

Comparison of FDG PET and SPECT for Detection of Bone Metastases in Breast Cancer

Takayoshi Uematsu, Sachiko Yuen, Seigo Yukisawa et al. · American Journal of Roentgenology · 2005 · 139 citations

Medicine, Nuclear Medicine, Oncology +17

Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

Kohei Shitara, Kei Muro, Yasuhiro Shimada et al. · Gastric Cancer · 2015 · 86 citations · Full text

Medicine, Oncology, Pharmacology +9

Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

Yuta Maruki, Chigusa Morizane, Yasuhito Arai et al. · Journal of Gastroenterology · 2020 · 55 citations · Full text

Medicine, Oncology, Pathology +17